LAA Occlusion Device

LAA Occlusion Device Guest: Mohamad Adnan (Mohamad) Alkhouli, M.D. (@adnanalkhouli) Host: Paul A. Friedman, M.D. (@drpaulfriedman) Left atrial appendage closure is an alternative to blood thinners for patients with atrial fibrillation who are at increased risk of stroke — but who are also intolerant of blood thinners for stroke prevention. Joining us today to discuss the use of left atrial appendage occlusion devices for this select group of patients is Mohamad Adnan (Mohamad) Alkhouli, M.D., an interventional cardiologist at Mayo Clinic in Rochester, Minnesota. Specific topics discussed: Patient eligibility for left atrial appendage occlusion Therapies other than blood thinners for stroke prevention Results of surgery vs. transcatheter closure for patients with atrial fibrillation The patient experience with Mayo Clinic's minimally invasive approach Follow-up anticoagulation or dual antiplatelet therapy Reduced risk of blood clots forming on the occlusion device Advances in the field and related clinical trials Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV. NEW Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.